diallyl trisulfide has been researched along with Carcinoma, Ehrlich Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Sherbiny, M; Elsherbiny, NM; Zaitone, SA | 1 |
| Iciek, M; Marcinek, J; Mleczko, U; Włodek, L | 1 |
2 other study(ies) available for diallyl trisulfide and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Diallyl trisulfide potentiates chemotherapeutic efficacy of doxorubicin in experimentally induced mammary carcinoma: Role of Notch signaling.
Topics: Allyl Compounds; Animals; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Survival; Doxorubicin; Female; Humans; Mice; NF-kappa B; Signal Transduction; Sulfides | 2020 |
Selective effects of diallyl disulfide, a sulfane sulfur precursor, in the liver and Ehrlich ascites tumor cells.
Topics: Allyl Compounds; Animals; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cyanides; Cystathionine gamma-Lyase; Disulfides; Dose-Response Relationship, Drug; Female; Garlic; Glutathione; Liver; Mice; Neoplasms, Experimental; Protective Agents; Sulfhydryl Compounds; Sulfides; Sulfur Compounds; Sulfurtransferases; Thiosulfate Sulfurtransferase | 2007 |